ArticleThe international journal of cardiovascular imaging2026
Longitudinal cardiac MRI assessment in constrictive pericarditis: a case series.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Longitudinal cardiac MRI assessment in constrictive pericarditis: a case series".The international journal of cardiovascular imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diagnosing and monitoring of constrictive pericarditis (CP) is challenging. Cardiac magnetic resonance imaging (CMR) offers superior visualization of pericardial thickness, inflammation, and fibrosis, helping assess disease progression and treatment response. This case series explores the role of CMR in monitoring CP, tracking disease progression, assessing treatment response, and guiding clinical decisions. This case series included six patients with CP who underwent serial CMR imaging. Clinical data and CMR findings—such as pericardial thickness, late gadolinium enhancement (LGE), T2 STIR signal, and ventricular interdependence—were recorded before and after treatment. CMR effectively tracked changes in pericardial structure and function over time. Persistent pericardial thickening and LGE were common, even after symptomatic improvement. Inflammatory activity is often reduced with treatment, but signs of constriction could remain. CMR helped distinguish reversible inflammation from irreversible fibrosis and guided decisions such as continued medical therapy or pericardiectomy. Serial CMR is a valuable tool in managing CP, offering insights into disease activity, treatment effectiveness, and functional impact. Persistent imaging abnormalities despite clinical improvement highlight the need for long-term monitoring and individualized treatment strategies.
Indexed as
Identifiers
41342994What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.